IFI-M · HUB Tri-Axis Dominant-Primary Series

Specimen SS-F-M3-00694 // MULTI-AXIS · IFI-M

HUB Tri-Axis Dominant-Primary Series IV-IV

Capsicum chinense

Habanero

Tier IVHUB Tri-Axis Dominant-Primary Series

Target Trait

2.38×

fold-change

Heat-dominant tri-axis U+B modulated fold-change

Technical Specifications

SKU

SS-F-M3-00694

Genomic Edits

11

GC Content

45.4%

Construct Length

6,114 bp

Promoter System

T7/SP6 cell-free

Expression System

In-vitro cell-free

Host Strain

Cell-free

Receptor Target

TRPV1 + mGluR1 + TAS2R38 (suppression)

IFI Score

238

Pathway Edits

  • TRPV1 pathway primary gene cluster for heat (IFI-H) tri-axis component
  • mGluR1 pathway primary gene cluster for umami (IFI-U) tri-axis component
  • TAS2R38 (suppression) pathway primary gene cluster for bitter-attenuation (IFI-B) tri-axis component
  • Tri-axis metabolic flux partitioning hub for concurrent HUB pathway operation
  • Cross-pathway regulatory circuit for heat-dominant HUB triple-axis expression
  • Cofactor regeneration system (NADPH, ATP, acetyl-CoA) supporting triple-axis concurrent production

Key Interventions

Triple-axis receptor co-activation: TRPV1, mGluR1, and TAS2R38 (suppression) pathways simultaneously engineeredHeat-dominant tri-axis expression strategy (HUB) with cross-pathway flux managementCell-free co-translation of multi-axis enzyme sets for in-vitro biochemical validation

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
—
IFI-K
—
IFI-C
—
IFI-P
—
IFI-A
—
IFI-F
—

Use Case

Tier IV HUB triple-axis construct for advanced multi-modal sensory architecture combining heat, umami, and bitter-attenuation axes. Suitable for ultra-premium ingredient formulation requiring certification across three simultaneous IFI receptor pathways.

License

$3999 · Tier IV License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Multi-Axis · IFI-MAll Modalities